merestinib
Showing 1 - 8 of 8
NSCLC, Solid Tumor Trial in Boston (Merestinib)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Solid Tumor
- Merestinib
-
Boston, Massachusetts
- +1 more
Jan 26, 2022
Bone Metastases, Breast Cancer Trial in Salt Lake City (Merestinib)
Terminated
- Bone Metastases
- Breast Cancer
- Merestinib
-
Salt Lake City, UtahHuntsman Cancer Institute
Jan 7, 2021
Relapsed Adult Acute Myeloid Leukemia, Refractory Adult Acute Myeloid Leukemia Trial in Boston (Merestinib, LY2874455)
Completed
- Relapsed Adult Acute Myeloid Leukemia
- Refractory Adult Acute Myeloid Leukemia
- Merestinib
- LY2874455
-
Boston, Massachusetts
- +1 more
Jun 29, 2020
Solid Tumor, Microsatellite Instability-High (MSI-H) Solid Tumors, Cutaneous Melanoma Trial in Worldwide (LY3300054,
Active, not recruiting
- Solid Tumor
- +4 more
- LY3300054
- +4 more
-
Nashville, Tennessee
- +14 more
Jul 21, 2022
Advanced Cancer, Metastatic Cancer, Biliary Tract Carcinoma Trial in Chiba, Tokyo (Merestinib, Cisplatin, Gemcitabine)
Completed
- Advanced Cancer
- +6 more
- Merestinib
- +2 more
-
Chiba, Japan
- +1 more
May 18, 2020
Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)
Active, not recruiting
- Biliary Tract Cancer
- +2 more
- Ramucirumab
- +5 more
-
Tucson, Arizona
- +91 more
Oct 18, 2022
Healthy Trial in Daytona Beach (Merestinib)
Completed
- Healthy
- Merestinib
-
Daytona Beach, FloridaCovance Clinical Research Inc
Aug 25, 2016